Article Information
History
- June 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Padmanabha Shenoy1,*,
- Sakir Ahmed2,
- Somy Cherian1,
- Aby Paul1,
- Veena Shenoy3,
- Anuroopa Vijayan1,
- Reshma Reji1,
- Arya Thampi1,
- AS Sageer Babu1 and
- Manju Mohan1
- 1Center for arthritis and Rheumatism excellence, Nettor
- 2Rheumatology, Centre for Arthritis and Rheumatism Excellence, Kochi, India 3 Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, Bhubaneswar, Odisha, India
- 3Amrita Institute of medical science, Kochi
- ↵*Corresponding Author : Dr Padmanabha Shenoy, Centre for arthritis and rheumatism excellence (CARE), Nettoor, Kochi, Kerala 682040, India, Email: drdpshenoy{at}gmail.com
Posted June 07, 2021.
Immunogenicity of the ChAdOx1 nCoV-19 and the BBV152 Vaccines in Patients with Autoimmune Rheumatic Diseases
